Eleven Biotherapeutics (EBIO) Swings to Q3 Profit

November 14, 2016 7:11 AM EST
Get Alerts EBIO Hot Sheet
Trade EBIO Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q3 EPS of $0.95, versus $0.50 reported last year. Revenue for the quarter came in at $28.7 million, versus $100 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment